Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stag...
Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Cardiovascular disease (CVD) is the leading cause of death in patients with chronic kidney disease (CKD). Osteoprotegerin (OPG), known to regulate bone mass by inhibiting osteoclast differentiation and activation, might also play a role in vascular calcification. Increased circulating OPG levels in patients with CKD are associated with aortic calci...
Alternative Titles
Full title
Osteoprotegerin is a marker of cardiovascular mortality in patients with chronic kidney disease stages 3–5
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_ddd2f065189e4944b811bc2715871624
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_ddd2f065189e4944b811bc2715871624
Other Identifiers
ISSN
2045-2322
E-ISSN
2045-2322
DOI
10.1038/s41598-021-82072-z
